05/27/2026
Research like this only happens when people choose to fund what has been ignored for far too long.
Because of your support, over $171,000 was dispersed to the Society of Gynecologic Surgeons across three payments to help complete the VULVIE Trial, a randomized controlled study examining vulvar fractionated CO2 laser therapy with and without topical clobetasol for the treatment of Vulvar Lichen Sclerosus (VLS).
VLS is chronic, painful, underdiagnosed, and too often dismissed. Patients deserve more than symptom management—they deserve evidence, options, and better standards of care.
This is what impact looks like:
funding research,
advancing treatment,
and changing lives.
Your support helps move women’s s*xual health forward.